Last €33.92 EUR
Change Today +0.205 / 0.61%
Volume 92.1K
As of 10:16 AM 07/14/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hartmut Retzlaff

Chairman of the Executive Board and Chief Executive Officer of the Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 70 board members in 2 different organizations across 5 different industries.

See Board Relationships
61€3,243,729
As of Fiscal Year 2013

Background*

Mr. Hartmut Ulrich Retzlaff serves as the Chief Executive Officer of Stada-Arzneimittel AG and has been its Chairman of Executive Board since 1994. Mr. Retzlaff serves as Member of the Executive Board at Stada Arzneimittel AG. He serves as Member of Exchange Council at Frankfurt Stock Exchange. He served as Chief Executive Officer, Chairman and Member of the Executive Board of Stada Pharmaceuticals, Inc. From 1986 to 1990, he served as Director of Marketing and Distribution ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary€2,000,000
Bonus€1,213,800
Total Annual Compensation€3,213,800

Stock Options*

All Other Compensation€29,930

Total Compensation*

Total Annual Cash Compensation€3,243,729
Total Short Term Compensation€3,213,800
Other Long Term Compensation€29,929
Total Calculated Compensation€3,243,729
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAZ:GR €33.92 EUR +0.205

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Ian R. Garland Chief Executive Officer, Director and Member of Nominations & Corporate Governance Committee
Vernalis plc
610.0K GBP
Peter Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Erik Bogsch Chief Executive Officer, Managing Director, Member of Executive Board and Director
Chemical Works of Gedeon Richter Plc
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.